Comirnaty (tozinameran, BNT162b2) Pfizer

About Us
- Get to know Avivir
  
  Innovation and investment in pharmaceuticals
  
  The "Avivir" group of companies is a research, production, and investment organization engaged in the development of advanced medical devices, technologies, and innovative pharmaceutical products.
- Partners and clients
  
  Collaborating with leading companies
  
  Our clients and partners are industry leaders and innovative startups.
Services
- Medical Institution Equipment
  
  At our company, we offer complete equipment solutions for healthcare institutions, tackling the most complex demands in the sector. We collaborate with top global manufacturers, procuring a diverse array of equipment essential for diagnostics, treatment, and surgical procedures.
- Medical Device Registration
  
  Offering comprehensive, professional, and expedited support for medical device registration.
Products
- Diagnostic tests
  
  Diagnostic tests
  
  Covid-19 tests
  Syphilis diagnostic tests
  Hepatitis diagnostic tests
- Medical equipment
  
  Everything for equipping institutions
  
  Obstetrics and Gynecology
  Anesthesiology and Resuscitation
  Gastroenterology
  Traumatology and Orthopedics
  Dentistry and Dental Prosthetics
  All equipment
- Parapharmaceuticals
  
  Parapharmaceuticals
  
  We offer the opportunity to 'engineer' sought-after dietary supplements from high-quality and safe raw materials - recipes that meet the demands of consumers and adhere to the latest health and wellness trends.
Contacts

About Us
- Get to know Avivir
  
  Innovation and investment in pharmaceuticals
  
  The "Avivir" group of companies is a research, production, and investment organization engaged in the development of advanced medical devices, technologies, and innovative pharmaceutical products.
- Partners and clients
  
  Collaborating with leading companies
  
  Our clients and partners are industry leaders and innovative startups.
Services
- Medical Institution Equipment
  
  At our company, we offer complete equipment solutions for healthcare institutions, tackling the most complex demands in the sector. We collaborate with top global manufacturers, procuring a diverse array of equipment essential for diagnostics, treatment, and surgical procedures.
- Medical Device Registration
  
  Offering comprehensive, professional, and expedited support for medical device registration.
Products
- Diagnostic tests
  
  Diagnostic tests
  
  Covid-19 tests
  Syphilis diagnostic tests
  Hepatitis diagnostic tests
- Medical equipment
  
  Everything for equipping institutions
  
  Obstetrics and Gynecology
  Anesthesiology and Resuscitation
  Gastroenterology
  Traumatology and Orthopedics
  Dentistry and Dental Prosthetics
  All equipment
- Parapharmaceuticals
  
  Parapharmaceuticals
  
  We offer the opportunity to 'engineer' sought-after dietary supplements from high-quality and safe raw materials - recipes that meet the demands of consumers and adhere to the latest health and wellness trends.
Contacts

Comirnaty (tozinameran, BNT162b2) Pfizer

In November 2020, Pfizer and BioNTech announced that their jointly developed vaccine had achieved an effectiveness of over 90%. Currently, the vaccine is still in Phase III clinical trials, which will include more than 40,000 volunteers.

Pfizer

On December 21, 2020, the Comirnaty vaccine was approved by the European Medicines Agency for emergency use, followed by the World Health Organization on December 31 of the same year.

Vaccine

Comirnaty (tozinameran, BNT162b2) Pfizer

Разработчик

BioNTech, in collaboration with Pfizer (USA) and Fosun Pharma (China)

Producer

Three Pfizer factories in the United States supply the North American market
A factory in Puurs (Belgium) supplies Europe and other countries

Status

The vaccine is currently in Phase III clinical trials.

Key information

What’s in the vaccine?

This is an mRNA vaccine consisting of nucleoside-modified mRNA which code a mutant form of SARS-CoV-2 spike protein, all encapsulated in lipid nanoparticles.